Evaluation of Ruxolitinib, a Janus Kinase Inhibitor, in Multiple Myeloma oncotarget.net - Blog, 07 Feb 2024 PRESS RELEASE: On February 5, 2024, a new research perspective was published in Oncotarget, entitled, “Preclinical and clinical…